Medicinal cannabis company Little Green Pharma (LGP) has updated the market on its financial and operational activities over 2020's final quarterIn terms of finances, LGP's quarterly sales revenue hit $2.45 million, marking a 90 per cent upswing on the previous quarter
All up, cash receipts for the period came in at $1.86 million, taking LGP's cash position for the quarter to just shy of $4.5 million
The ASX-lister also continued its international market pursuits, completing its fist export to Germany and receiving a primary supplier role for a national French medicinal cannabis trial
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)